FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Hetero Drugs Ltd. - Unit 1 Finasteride Tablets Recall

Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pha…

Hetero Drugs Ltd. - Unit 1 · Medak District, N/A

Risk level
Class III
Reported by FDA
Feb 8, 2017
Recall ID
D-0453-2017
Check your lot numberHow we source this data

Summary

Hetero Drugs Ltd. - Unit 1 recalled Finasteride Tablets starting Dec 29, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0453-2017 on Feb 8, 2017. Reason: Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.

Product description

Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs, Unit V Polepally, Jadcheria, Mahaboob Nagar - 509 301, India Limited NDC 31722-525-90

Lot numbers, UPCs & expiration codes

Lot #: FIN16002, Exp. 03/2018

Where it was sold

NJ only.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0453-2017
Classification
Class III
Status
Terminated
Recall initiated
Dec 29, 2016
FDA report date
Feb 8, 2017
Quantity
20,412 units
Recall type
Voluntary: Firm initiated
Recalling firm
Hetero Drugs Ltd. - Unit 1

Original FDA data

Every field from FDA enforcement report D-0453-2017, exactly as published.

Show all FDA fields
City
Medak District
Status
Terminated
Country
India
Event ID
76120
Address
Plot Nos. 213, 214, 255
Address (line 2)
Bonthapally Village, Jinnaram Mandal
Code information
Lot #: FIN16002, Exp. 03/2018
Report date
Feb 8, 2017
Product type
Drugs
Recall number
D-0453-2017
Classification
Class III
Recalling firm
Hetero Drugs Ltd. - Unit 1
Product quantity
20,412 units
Termination date
Jul 11, 2017
Reason for recall
Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs, Unit V Polepally, Jadcheria, Mahaboob Nagar - 509 301, India Limited NDC 31722-525-90
Distribution pattern
NJ only.
Recall initiation date
Dec 29, 2016
Initial firm notification
Letter
Center classification date
Jan 31, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0453-2017, published Feb 8, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls